Incite Health

Our proprietary CNSDose test connects your unique genetics with the latest clinical neuroscience to give you more accurate recommendations, alleviating trial and error of dosage for medications related to depression and anxiety. With a simple at-home cheek swab to collect your DNA, the CNSDose test analyses 15 of your genes. Some of these genes can affect the liver's ability to metabolise medications and others help carry medication to the brain via the blood-brain barrier. Genetic differences in a person can mean they metabolise medications slower or faster, or the medication has difficulty reaching the brain. CNSDose anticipates such responses in you, giving evidence-based dosage recommendations to your Physician tailored to your genetic make-up. Our service specialty is molecular genetics and our own labs receive, process and report on your tests. With accreditation from the National Association of Testing Authorities (NATA) and the Royal Australasian College of Pathologists in Australia, we ensure the results we send you and your Physician are of the highest standards and quality. The Incite Health labs are also compliant with both the National Pathology Accreditation Advisory Council (NPAAC) and ISO15189 requirements, which means we follow international standards recognized by the Australian government. CNSDose is available today for both patients and medical professionals. To get more information on CNSDose and stay informed on upcoming products and tests related to mental, reproductive and sexual wellness, please contact us directly at: info@incitehealth.com.au.